Get started
Author

Milena Matuszczak

Observed name: Milena Kiljańczyk
ORCID: 0000-0001-8050-1507
Observed ORCID: 0000-0001-8050-1507
OpenAlex ID: A5064708463
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
2021 · Milena Matuszczak, Jack A. Schalken, et al. · Cancers · 79
PDF
A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
2022 · Milena Matuszczak, Adam Kiljańczyk, et al. · International Journal of Molecular Sciences · 65
PDF
Serum Essential Elements and Survival after Cancer Diagnosis
2023 · Jan Lubiński, Marcin R. Lener, et al. · Nutrients · 42
PDF
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
2020 · Milena Matuszczak, Maciej Salagierski · International Journal of Molecular Sciences · 41
PDF
Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers
2024 · Milena Matuszczak, Adam Kiljańczyk, et al. · Antioxidants · 26
Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review
2023 · Milena Matuszczak, Adam Kiljańczyk, et al. · Cancers · 25
PDF
Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
2024 · Sandra Pietrzak, Wojciech Marciniak, et al. · Nutrients · 18
PDF
Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers
2024 · Milena Matuszczak, Adam Kiljańczyk, et al. · Antioxidants · 16
Pro/antioxidant status and selenium, zinc and arsenic concentration in patients with bipolar disorder treated with lithium and valproic acid
2024 · Joanna Rog, Łukasz Łobejko, et al. · Frontiers in Molecular Neuroscience · 14
PDF
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers
2024 · Milena Matuszczak, Adam Kiljańczyk, et al. · Hereditary Cancer in Clinical Practice · 13
PDF
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers
2024 · Adam Kiljańczyk, Milena Matuszczak, et al. · Nutrients · 12
The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy
2022 · Milena Matuszczak, Adam Kiljańczyk, et al. · Biomedicines · 10
PDF
Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational Exposure
2025 · Krzysztof Lubiński, Marcin R. Lener, et al. · Biomedicines · 9
PDF
Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients
2024 · Sandra Pietrzak, Wojciech Marciniak, et al. · Cancers · 7
Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer
2024 · Elżbieta Złowocka-Perłowska, Piotr Baszuk, et al. · Biomedicines · 6
Oligometastatic Disease in Prostate Cancer. Evolving paradigm: current knowledge, diagnostic techniques and treatment strategies
2022 · Milena Matuszczak, Maciej Salagierski · Archives of Medical Science · 6
PDF
Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers
2024 · Adam Kiljańczyk, Milena Matuszczak, et al. · Nutrients · 5
The Role of (Dis)information in Society During the COVID-19 Pandemic
2021 · Zuzanna Czudy, Milena Matuszczak, et al. · Problemy Zarządzania - Management Issues · 2
The Potential Role of Vitamin D in BRCA1 Pathogenic Variant Carriers: A Narrative Review
2026 · Joanna Robaczyńska, Milena Kiljańczyk, et al. · International Journal of Molecular Sciences
Works count: 19
Citation count: 396
H-index: 11
I10-index: 12
Year
Topic
Type